Research & Innovation
Publications
Durvalumab prolongs overall survival whereas radiation dose escalation >66 Gy improves long-term local control in unresectable NSCLC stage III: Updated analysis of the Austrian radio-oncological lung cancer study association registry (ALLSTAR)
PMU Authors
Franz Zehentmayr, Elvis Ruznic, Brane Grambozov
All Authors
Franz Zehentmayr, Petra Feurstein, Elvis Ruznic, Brigitte Langer, Brane Grambozov, Marissa Klebermass, Ayurzana Purevdorj, Georg Gruber, Danijela Minasch, Martin Heilmann, B. Breitfelder, Claudia Steffal, Gisela Gastinger-Grass, Karoline Kirchhammer, M. Kazil, Heidi Stranzl, Karin Dieckmann
Journal association
JOURNAL OF THORACIC ONCOLOGY